Additionally, it has been shown that deletion of one of such regulators—Rab27A, leading to the elimination of exosomal programmed death-ligand 1 (PD-L1), can block the development of cancer tissue by stimulating anti-tumor immunity [26, 59, 113, 114]. Here, CD274 is linked to cancer.